Please assess the completion status of the following clinical trial:

Trial Title: Phase 1 Study(Additional) of URC102 in Healthy Subjects

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE1
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Healthy male volunteers~Exclusion Criteria:~* Participated in other clinical study within past 3 months prior to receiving an IP administration

- Gender: MALE
- Minimum Age: 20 Years
- Maximum Age: 49 Years
- Healthy Volunteers: t

Study Arms:
- Placebo (Type: PLACEBO_COMPARATOR): Placebo
- URC102 (Type: ACTIVE_COMPARATOR): URC102

Based on this trial design, predict the completion outcome and termination type (if applicable).